Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies

CONCLUSIONS: The KRS is a valid tool to predict VTE and mortality in a cohort of Hispanic outpatients with newly diagnosed solid tumours.PMID:36819798 | PMC:PMC9934874 | DOI:10.3332/ecancer.2022.1470
Source: Ecancermedicalscience - Category: Cancer & Oncology Authors: Source Type: research